Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brain Microglial Activation in Neuropsychiatric Syndromes
NCT03705715Phase 1Recruiting
- Sponsor
- UTHealth Houston
- Start
- May 2017
- Primary completion
- Aug 2028
- Countries
- 1
01
Overview
Phase 1, open-label trial (2 arms), sponsored by UTHealth Houston. Primary endpoint: Level of TSPO expression at Day 1. Started May 2017; status: recruiting.
Beyond the preview
Go deeper on NCT03705715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03705715.